Literature DB >> 8847085

Modulation of drug-induced apoptosis in a human B-lymphoma cell line (HT58).

R Mihalik1, L Kopper, M Benczúr.   

Abstract

The cytotoxic effect of etoposide (ETO), a topoisomerase II inhibitor, and staurosporine (STA), a non-selective protein kinase inhibitor, were studied on a human lymphoma cell line of B-cell origin (HT58). Apoptosis, induced dose dependently by both drugs, was accompanied with nucleosomal DNA fragmentation detected by flow cytometry. On the other hand, induction of cell death failed using phorbol ester (PMA), anti-IgM antibody (a-IgM) or dexamethasone (DEX), although, all of these agents arrested the cells in G1. Furthermore, PMA pretreatment retarded ETO-induced apoptosis, but enhanced STA cytotoxicity. DEX increased the sensitivity of cells to STA, but did not to ETO. Activity of STA or DEX was only slightly modified by a-IgM pretreatment. The results support the possibility that different apoptotic pathways exist in HT58 cells. The differences in pathways could be manifested either in the signaling routes, or in the molecular effectors of apoptosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8847085     DOI: 10.1016/0165-2478(95)02434-4

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

1.  Formaldehyde promotes and inhibits the proliferation of cultured tumour and endothelial cells.

Authors:  E Tyihák; J Bocsi; F Timár; G Rácz; B Szende
Journal:  Cell Prolif       Date:  2001-06       Impact factor: 6.831

2.  Detection of Drug-induced Apoptosis by Flow Cytometry after Alkaline Extraction of Ethanol Fixed Cells.

Authors:  Rudolf Mihalik; Ferenc Uher; Lajos Berczi; Miklós Benczur; László Kopper
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

3.  Regulation of Differentiation, Proliferation and Drug-Induced Apoptosis in HT58 Lymphoma Cells.

Authors:  Rudolf Mihalik; Ferenc Uher; Anna Sebestyén; Lászl&oacute Kopper
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.